Toremifene citrate salt

• Catalog No.: T7204
• CAS Number: 89778-27-8
• M. F.: C32H36ClNO8
• M. W.: 598.08314
• Purity: ≥98% (HPLC)
• Storage: desiccated

SYNONYMS

• IUPAC name: 2-hydroxypropane-1,2,3-tricarboxylic acid; {2-[4-(4-chloro-1,2-diphenylbut-1-en-1-yl)phenoxy]ethyl}dimethylamine
• IUPAC Traditional name: citro; {2-[4-(4-chloro-1,2-diphenylbut-1-en-1-yl)phenoxy]ethyl}dimethylamine
• Synonyms: Z-Toremifene; (Z)-2-(4-(4-Chloro-1,2-diphenyl-1-butenyl)phenoxy)-N,N-dimethylethanamine; Acapodene; Fareston; GTx 006

DATABASE IDS

• CAS Number: 89778-27-8
• MDL Number: MFCD01729016

PROPERTIES

• Empirical Formula (Hill Notation): C26H28ClNO · C6H8O7
• Purity: ≥98% (HPLC)
• Apperance: white to off-white powder
• Solubility: DMSO: >10 mg/mL
• GHS Signal Word: Danger
• GHS Hazard statements: H302-H318-H410
• European Hazard Symbols: Harmful (Xn)
• European Hazard Symbols: Nature polluting (N)
• GHS Precautionary statements: P273-P501
• RID/ADR: UN 3077 9/PG 3
• Risk Statements: 22-41-50/53
• RTECS: KH2156700
• Safety Statements: 26-39-60-61
• Storage Condition: desiccated
• Storage Temperature: 2-8°C
• Hazard Class: 9
• UN Number: 3077
• Packing Group: 3
• German water hazard class: 3

DETAILS

Description (简体中文)

Biochem/physiol Actions
Toremifene citrate is an oral selective estrogen receptor modulator (SERM). Toremifene citrate is used in advanced (metastatic) breast cancer and being evaluated for prevention of prostate cancer.

Description (English)

Biochem/physiol Actions
Toremifene citrate is an oral selective estrogen receptor modulator (SERM). Toremifene citrate is used in advanced (metastatic) breast cancer and being evaluated for prevention of prostate cancer.